Please Refute Reefer Mania

[Nargyle]

DrugSense FOCUS Alert #351 - Sunday, 29 July 2007

On Friday, the British medical journal Lancet published a 13 page
meta-analysis 'Cannabis Use and Risk of Psychosis in Later Life.'

As a result the media around the world has used the study, most often
with incorrect data and conclusions, to create another reefer mania
scare.

Backers of stern cannabis prohibition laws have seized on this news
to urge the British government to increase the potential punishment
of users under their laws.

More reasoned voices have cautioned that escalating criminal
penalties based on a perceived increased health risk would be
counterproductive. See 'Experts Dismiss Case for Cannabis
Reclassification' http://www.mapinc.org/drugnews/v07/n901/a05.html

MAP is continually archiving both international and domestic coverage
of the issue as we receive clippings. These press clippings may be
reviewed by using the following link, which is updated nightly. Note
that MAP identifies press stories by the location of the story. Thus
a number at the link are identified as "UK:" but are actually from
newspapers in the United States or Canada.

http://www.mapinc.org/topics/psychosis

Please consider writing and sending Letters to the Editor to the
newspapers of your choice. It is important that mainstream newspaper
editors and opinion writers are given a more complete and balanced
perspective than that being pushed by prohibitionists. If you elect
to write to more than one newspaper, we suggest at least some
modification of your message so that each newspaper receives a unique
letter.

Thanks for your effort and support.

It's not what others do, it's what YOU do.

[BackToBasics]

Good idea, this was similar to what Budgie was trying to get at in the thread about the rise in psychosis incidence. Everybody who uses Cannabis should do this, then people might start to listen..

[Heretic.Ape.]

Great post, for some more info on using this resource feel free to check out this post on
How to reform drug policy using DrugSense / MAP